Skip to content

Dosing Music for Anxiety Reduction in Parturients

Estimating the Effective Dose of Music Duration for Anxiety Reduction Prior to Cesarean Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05966766
Enrollment
40
Registered
2023-08-01
Start date
2023-12-07
Completion date
2024-05-31
Last updated
2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

This is a clinical study that aims to determine the effective dose of music listening duration that is required to reduce anxiety in patients awaiting scheduled cesarean section. It will also compare types of music to accomplish this goal, both of which have been shown effective in prior studies. Methods will involve enrolling and playing music for patients awaiting scheduled C-section, and scoring their anxiety with pre- and post-music questionnaires. Music duration for each subject will be predetermined, and analysis of response will be performed to determine the effective dose 95%, or dose at which 95% of subjects should have a positive response.

Interventions

OTHERMozart selections

Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time. Music will be selections by Mozart of previously studied and shown to reduce anxiety.

OTHERPatient-preferred music selections

Music will be played from a speaker connected to a media-playing device for participants to listen to for set durations of time. Music will be selections of patient choice.

Sponsors

Tufts Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Planning on scheduled cesarean section or non-emergent unscheduled cesarean section * Able to provide informed consent * American Society of Anaesthesiologists (ASA) physical status score of II-III

Exclusion criteria

* Patient refusal * Impaired hearing * Patient is taking at least one anxiolytic medication daily at baseline * No anxiety (a score of 0, on a scale of 0-10, of pre-music exposure anxiety) after consent is given * ASA IV or higher

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Score4-8 minutesVerbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.

Secondary

MeasureTime frameDescription
STAI4-8 minutes6-question abbreviated state-trait anxiety inventory (STAI) questions asked and scored on a 6-24 point scale (higher is more anxiety) for before and after intervention. Decrease in score after intervention was considered a positive response, with larger decreases indicating better responses.

Countries

United States

Participant flow

Participants by arm

ArmCount
Mozart
Subjects in this arm listened to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
20
Patient Preference
Subjects in this arm listened to music from a list of pre-selected pieces of their own choosing.
20
Total40

Baseline characteristics

CharacteristicMozartPatient PreferenceTotal
Age, Continuous32.7 Years
STANDARD_DEVIATION 5.4
33.5 Years
STANDARD_DEVIATION 4.9
33.0 Years
STANDARD_DEVIATION 5.1
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants4 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants16 Participants32 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Gestational age38.6 Weeks
STANDARD_DEVIATION 0.8
38.6 Weeks
STANDARD_DEVIATION 0.9
38.6 Weeks
STANDARD_DEVIATION 0.9
Gravidity2.4 Pregnancies
STANDARD_DEVIATION 1
3.6 Pregnancies
STANDARD_DEVIATION 1.3
3 Pregnancies
STANDARD_DEVIATION 2.2
Parity1.1 Births
STANDARD_DEVIATION 0.8
1.3 Births
STANDARD_DEVIATION 1.4
1.2 Births
STANDARD_DEVIATION 1.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Black or African American
8 Participants5 Participants13 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
10 Participants12 Participants22 Participants
Sex: Female, Male
Female
20 Participants20 Participants40 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Anxiety Score

Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.

Time frame: 4-8 minutes

ArmMeasureGroupValue (MEAN)Dispersion
MozartAnxiety ScoreAfter3.6 score on a scaleStandard Deviation 2.3
MozartAnxiety ScoreBefore5.9 score on a scaleStandard Deviation 2.6
Patient PreferenceAnxiety ScoreBefore6.1 score on a scaleStandard Deviation 2.3
Patient PreferenceAnxiety ScoreAfter3.1 score on a scaleStandard Deviation 2.4
Secondary

STAI

6-question abbreviated state-trait anxiety inventory (STAI) questions asked and scored on a 6-24 point scale (higher is more anxiety) for before and after intervention. Decrease in score after intervention was considered a positive response, with larger decreases indicating better responses.

Time frame: 4-8 minutes

ArmMeasureGroupValue (MEAN)Dispersion
MozartSTAIBefore12.7 score on a scaleStandard Deviation 4.3
MozartSTAIAfter10.3 score on a scaleStandard Deviation 3.2
Patient PreferenceSTAIBefore14.4 score on a scaleStandard Deviation 4.1
Patient PreferenceSTAIAfter10.8 score on a scaleStandard Deviation 3.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026